All Type of News
Government seeking guidelines for fair tradeThe Fair Trade Commission (FTC) said on December 18 that the commission would pool opinions from the industry and relevant government ministries to present guidelines to deal wi...
|
.jpg)
Tougher action needed to root out illegal practiceThe Korean Pharmaceutical Association is calling for tougher measures, including legal action, against the violating drug makers, wholesalers and hospitals in order to ensure fa...
|
Designation of eligible bioequivalence testing centers eyed
The government plans to make public its revised guideline over the designation of eligible bioequivalence testing centers as part of efforts to prevent any false testing results, according to the Korea Food and Drug A...
KPA to sell welfare devices for elderly people
The Korean Pharmaceutical Association has announced its plan to sell a variety of devices aiming to help promote the welfare of elderly people.
“We've been seeing rising demand among elderly people recently and dec...
Merck to offer scholarship to Koreans
Merck Ltd, the Korean subsidiary of Merck KGaA, signed a memorandum of understanding on December 18 with College of Medicine, Seoul National University to provide its scholarship to the college.
It is proposed for ...
Dong-A’s Stillen to be exposed to fiercer competition
The homegrown drug in Korea will not be as stale as before with a growing number of pharmaceutical companies poising to enter a 70 billion Stillen market.
More than 20 pharmaceutical manufacturers are expected to ...
Pharmaceutical industry calling for more tax cuts on R&D spendingThe government’s long-term plans for the development of new drugs should focus on more tax cuts levied on research and development (R&D) reserves, facility investment for resear...
|
Novartis Korea holds launching symposium for Exelon patch
The launching symposium for Exelon Patch (rivastigmine transdermal patch) was held in Cheju, it was announced on December 18.
“Exelon is a cholinesterase inhibitor, and it is thought to exert its therapeutic effect...
US FDA okays Ketotop patch as OTC productPacific Pharma says its anti-inflammatory pain reliever Ketotop (ketoprofen transdermal patch) has been registered to the US Food and Drug Administration as an over-the-counter ...
|
Chong Kun Dang to face uphill battle in cold drink market
Chong Kun Dang Pharmaceutical will face an uphill battle in the domestic cold drink market to survive fierce competition with its rivals, including Dong-A Pharm.
Chong Kun Dang has launched Penzal drink but restric...
